A convergence of synthesis and antimicrobial research: imidazolium based dicationic ionic liquids
- PMID: 40702486
- PMCID: PMC12285118
- DOI: 10.1186/s13065-025-01574-3
A convergence of synthesis and antimicrobial research: imidazolium based dicationic ionic liquids
Abstract
The rising challenge of developing effective antimicrobial agents to combat a broad spectrum of bacterial infections, while mitigating the risk of drug resistance, has prompted extensive exploration into alternative treatment strategies. This paper focuses on the synthesis and characterization of imidazolium-based dicationic ionic liquids with the aim of addressing this crucial healthcare need. A total of 16 distinct compounds were successfully synthesized and systematically characterized using Fourier-transform infrared spectroscopy (FTIR) and nuclear magnetic resonance (NMR) techniques. The investigation into the antibacterial activity of these ionic liquids showcased their potential as promising antimicrobial agents. Drawing on the advantageous properties of ionic liquids, such as reduced toxicity and outstanding antimicrobial efficacy. Our study specifically explores dicationic imidazolium-based ionic liquids with two different spacers: 1,3-dibromopropane and (E)-1,4-dibromobut-2-ene. Thorough analysis using 1H NMR, 13C NMR, FTIR, and TGA techniques provided valuable insights into the molecular structures and thermal properties of the synthesized compounds. Antibacterial assays were conducted to evaluate the efficacy of various combinations of these ionic liquids against bacterial strains, including Bacillus subtilis, Escherichia coli, Klebsiella pneumoniae, Staphylococcus aureus, and Methicillin-resistant Staphylococcus aureus. Remarkably, the ionic liquids containing the bisulphate anion exhibited exceptional antibacterial results compared to other combinations. The structure-activity relationship of the most prominent ionic liquids identified in the antibacterial assays was analyzed by DFT studies. Additionally, molecular docking was employed to investigate the molecular interactions involved in the antibacterial activities. ILs can be utilized as effective candidates against infections to avoid disabilities.
Keywords: Antibacterial; Dicationic; Disability; Docking; Imidazolium; Ionic liquids; Rehabilitation.
© 2025. The Author(s).
Conflict of interest statement
Declarations. Ethics approval and consent to participate: Ethical approval is not required for this type of research work. Consent for publication: Not applicable. Competing interests: The authors declare no competing interests.
Figures














Similar articles
-
A systematic review on natural products with antimicrobial potential against WHO's priority pathogens.Eur J Med Res. 2025 Jul 1;30(1):525. doi: 10.1186/s40001-025-02717-x. Eur J Med Res. 2025. PMID: 40597250 Free PMC article.
-
Novel ionic liquids with antibacterial and low cytotoxic properties for double-J stents.Urolithiasis. 2025 Aug 25;53(1):163. doi: 10.1007/s00240-025-01831-z. Urolithiasis. 2025. PMID: 40853571
-
Understanding Experimentally Compatible Bactericidal Activity of Dicationic Ionic Liquids: A Mechanistic Insight into the Effect of Functional Groups by MD Simulations.J Phys Chem B. 2025 Jun 19;129(24):5961-5975. doi: 10.1021/acs.jpcb.5c00942. Epub 2025 Jun 2. J Phys Chem B. 2025. PMID: 40455420
-
Biological activities of optimized biosynthesized selenium nanoparticles using Proteus mirabilis PQ350419 alone or combined with chitosan and ampicillin against common multidrug-resistant bacteria.Microb Cell Fact. 2025 Jul 5;24(1):159. doi: 10.1186/s12934-025-02783-0. Microb Cell Fact. 2025. PMID: 40618114 Free PMC article.
-
Management of urinary stones by experts in stone disease (ESD 2025).Arch Ital Urol Androl. 2025 Jun 30;97(2):14085. doi: 10.4081/aiua.2025.14085. Epub 2025 Jun 30. Arch Ital Urol Androl. 2025. PMID: 40583613 Review.
References
-
- Pendleton JN, Gilmore BF. The antimicrobial potential of ionic liquids: A source of chemical diversity for infection and biofilm control. Int J Antimicrob Agents. 2015;46(2):131–9. 10.1016/j.ijantimicag.2015.02.016. - PubMed
-
- Organization WH. Report on the burden of endemic health care-associated infection worldwide. 2011.
-
- Klassert TE, Zubiria-Barrera C, Neubert R, Stock M, Schneegans A, López M, Driesch D, Zakonsky G, Gastmeier P, Slevogt H, et al. Comparative analysis of surface sanitization protocols on the bacterial community structures in the hospital environment. Clin Microbiol Infect. 2022;28(8):1105–12. 10.1016/j.cmi.2022.02.032. - PubMed
-
- Rutala WA, Weber DJ. Disinfection and sterilization in health care facilities: what clinicians need to know. Clin Infect Dis. 2004;39(5):702–9. 10.1086/423182. - PubMed
LinkOut - more resources
Full Text Sources